Monoclonal antibody exposure during pregnancy and baby's immune system
Treatments studied
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at how monoclonal antibody treatments given during pregnancy affect a baby's immune system development. It compares babies whose mothers received these treatments throughout pregnancy, only in early pregnancy, or not at all.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant
- You have an immune-related inflammatory disease (like rheumatoid arthritis, psoriasis, lupus, or inflammatory bowel disease) or a cancer that requires treatment
- You either received a monoclonal antibody treatment during pregnancy, or you did not receive any monoclonal antibody treatment (or received a biologic that does not cross the placenta)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows pregnant people who took tildrakizumab to understand pregnancy outcomes and safety. It also compares them with pregnant people with the same underlying disease who did not take tildrakizumab during this pregnancy.
This study looks at the typical pregnancy course and outcomes for women with APS or UCTD, two autoimmune-related conditions. It also checks how these conditions and treatments may affect pregnancy, so doctors can better plan care.
This study looks at how certain multiple sclerosis medicines (called monoclonal antibodies) given during pregnancy might affect the baby's immune system. It will help doctors understand if these treatments are safe for the baby.
This study is a registry that collects information about COVID-19 during pregnancy, including what treatments were used and pregnancy outcomes. It may help doctors better understand the safety and effects of COVID-19 medicines in pregnancy.
This study looks at how the immune system works during pregnancy, focusing on women at high risk for preeclampsia. Researchers want to understand immune changes before any treatment is started.
This study looks at whether mothers pass certain antibodies through the placenta to their babies. It aims to understand how these antibodies travel from mother to child.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.